Keyphrases
Cognitive Impairment
100%
Cerebral Small Vessel Disease (cSVD)
88%
New-onset Refractory Status Epilepticus (NORSE)
88%
Interim Analysis
88%
Vascular Contributions
81%
Cognitive Dementia
81%
White Matter Hyperintensities
66%
Comparative Analysis
53%
Odds Ratio
48%
Oxygen Extraction Fraction
45%
Amyloid Deposition
44%
Critical Care Neurology
44%
Creutzfeldt-Jakob Disease
44%
Sleep Pathology
44%
Neurological Manifestations
44%
Olfactory Dysfunction
44%
Dysautonomia
44%
PiB-PET
44%
Multimodal Neuroimaging
44%
Cerebrovascular Physiology
44%
Neuroimaging Techniques
44%
Emergency Neurology
44%
Vascular Dementia
44%
Chronic Hydrocephalus
44%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
44%
Acute Hydrocephalus
44%
Neuroinflammation
44%
Alzheimer's Disease
44%
Alzheimer's Dementia
44%
Lesion Evolution
44%
Critical Illness
44%
Binding Potential
44%
Metabolism
44%
White Matter Injury
44%
Metabolic Stress
44%
Patient Management
44%
Monogenic
44%
Parkinson's Disease
44%
Fever
44%
Therapeutic Monoclonal Antibody
44%
Leukoencephalopathy
44%
Neurodegeneration
44%
Hydrocephalus
44%
Microvasculopathy
44%
Neuroimaging
44%
Trends in Management
44%
Febrile Infection-related Epilepsy Syndrome (FIRES)
44%
Anti-amyloid Monoclonal Antibody
44%
Systemic Manifestations
44%
Amyloid Imaging
44%
Neuroscience
Status Epilepticus
88%
Amyloid Protein
88%
Alzheimer's Disease
49%
Cognitive Disorders
48%
Immunotherapy
46%
Vascular Dementia
44%
Dysautonomia
44%
Creutzfeldt Jakob Disease
44%
Vascular Disease
44%
Parkinson's Disease
44%
Cerebrovascular Disease
44%
Leukoencephalopathy
44%
Neurodegeneration
44%
Hydrocephalus
44%
Subarachnoid Hemorrhage
44%
Monoclonal Antibody
44%
Autoantibodies
44%
Encephalitis
44%
Ischemia
43%
Polysomnography
35%
Rapid Eye Movement Sleep
26%
Diffusion Tensor Imaging
22%
Magnetic Resonance Imaging
19%
Ketogenic Diet
19%
Anakinra
19%
Limb Movement
17%
Neurodegenerative Disorder
17%
Magnetic Resonance Imaging
16%
Olfaction
14%
Non-Motor Symptoms
14%
Tocilizumab
12%
Positron Emission Tomography
11%
Arterial Spin Labeling
11%
In Vivo
10%
Sleep Time
8%
Rapid Eye Movement Sleep Behavior Disorder
8%
Hypersomnia
8%
Obstructive Sleep Apnea
8%
Restless Legs Syndrome
8%
Sleep Spindle
8%
Parasomnia
8%
Intraventricular Hemorrhage
7%
Cerebral Hemorrhage
7%
Rituximab
6%
Cognitive Function
5%
Chemokine
5%
CCL2
5%
Macrophage Inflammatory Protein 1
5%
Interleukin 6
5%
Beta Amyloid
5%